Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients

Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients

Abstract Background Neutralizing monoclonal antibodies (mAbs) are highly effective in reducing hospitalization and mortality among early symptomatic COVID-19 patients in clinical trials and real-world data. While resistance to some mAbs has since emerged among new variants, characteristics associate...

Full description

Bibliographic Details
Main Authors: David J. Douin, Adane F. Wogu, Laurel E. Beaty, Nichole E. Carlson, Tellen D. Bennett, Neil R. Aggarwal, David A. Mayer, Toan C. Ong, Seth Russell, Jeffrey Steele, Jennifer L. Peers, Kyle C. Molina, Matthew K. Wynia, Adit A. Ginde
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Infectious Diseases
Subjects:
COVID-19
SARS-CoV-2
Monoclonal antibodies
Online Access:https://doi.org/10.1186/s12879-022-07819-z

Internet

https://doi.org/10.1186/s12879-022-07819-z

Similar Items